Clinical Trial Update: Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining the immunogenicity and safety of a meningococcal group B vaccine in pediatric patients with autoimmune rheumatic diseases; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Rheumatic Disease

Drugs mentioned

• MenB vaccine (Meningococcal group B vaccine)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Autoimmune Rheumatologic Disease | Phase 4 | Status: RECRUITING